ASRS Presidents’ Young Investigator Award

The Retina Young Investigator Award was established to honor past leaders of ASRS. It serves as a means to nurture the development of the next generation of retina leaders and encourage researchers to undertake investigative work in critical areas of retinal diseases that may one day lead to meaningful improvements in patients’ lives.

The award is given in recognition of an outstanding paper published during the past year and other accomplishments of the investigator that signal potential for impactful contributions to the field in the future.

Submit a nomination »

 Eligibility Criteria

  • 45 years of age or younger at the time the paper is published
  • Member of the ASRS
  • Must be first or senior author on the paper submitted for consideration
  • Paper must be original and published in print or e-published in a peer-reviewed journal within the last 12 months (January 2017-December 2017)
  • Individuals may nominate themselves or others may nominate them once the paper has been published.
  • To be considered, nominees must submit the published paper, including all illustrations and online links, acknowledgement from senior author (if first author is applicant) or first author (if senior author is applicant) that candidate is in fact the primary investigator, a CV, and a paragraph summarizing the significance of their work (250 words or less).  

Award  

The Young Investigator Award will be given at the ASRS Annual Meeting, and the recipient will receive a $15,000 honorarium.

Application Process: The application materials will be submitted online to ASRS. The deadline for the 2018 Young Investigator Award is January 31, 2018, and it will be publicized in Retina FYI and by direct e-mails to members.

Review Process: The Foundation Executive Committee will serve as the awards committee and select the recipient.

A maximum of one award will be given per year at the discretion of the Foundation Executive Committee.

The ASRS  Young Investigator Award is made possible by grant from Regeneron.